[vc_row][vc_column][vc_column_text]
Ram May-Ron and Ayal Ronen of the FreeMind Group introduce the R&DMoneyView, a tool that will allow its users to gain insight into non-dilutive Federal awards made to domestic, for-profit organizations to support R&D in the Life Sciences.
R&DMoneyView is the first tool in the R&DMoney suite of tools designed to streamline the granting process in a cost-efficient manner while maximizing chances for award.
[/vc_column_text][/vc_column][/vc_row]
Representatives from federal agencies, a private foundation, and industry come together to provide insight into key industry-related initiatives from the various sources as well as the overall enthusiasm for awarding for-profit organizations.
Moderator: Ayal Ronen, FreeMind Group
Panelists:
Dr. Michael Kurilla, NIAID
Todd Merchak, NIBIB,
Dr. Mark Allegretta, National MS Society
Colonel Russell Coleman, DOD (JPM-MCS)
Dr. Natalie Wisniewski, Profusa, Inc.
Colonel Russell E. Coleman of the JPM-Medical Countermeasure Systems, presents the Keynote Address: The Dilemma in the Development of Medical Countermeasures Against Chemical and Biological Weapons: An unpredictable threat and products we hope will never be used.
Dr. Michael Kurilla of the National Institute of Allergy and Infectious Diseases takes a look at the progression of Infectious Diseases, where vaccine and treatment trends may be heading, and NIAID’s role in addressing unmet needs.
Todd Merchak of the National Institute of Biomedical Imaging and Bioengineering discusses SBIR, STTR, and other grants available to support innovative R&D in medtech.
Dr. Mark Allegretta of the National MS Society shares on the Fast Forward program and their investment methods.
Evelia Johnston of The Michael J. Fox Foundation for Parkinson’s Research speaks about venture philanthropy and how the MJFF works to fulfill the unmet funding needs of R&D targeting Parkinson’s Disease.
Life Science Nation founder Dennis Ford gives insight into fundraising and tips for approaching investors.
Dr. Jak Knowles of CureDuchenne Ventures sheds light on Duchenne Muscular Dystrophy, CureDuchenne’s role in seeking a cure, and its non-dilutive and venture philanthropy funding models supporting R&D.
FreeMind Group
6 Liberty Square #2783
Boston, MA 02109
We use cookies to gather web statistics that help us improve our site. We store no personal details.
OKLearn moreWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy Policy